Delivery Order SPE2DB25D3021-SPE2DB25FQYVA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a $4,156.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a pharmaceutical product used in hormone therapy, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orgovyx 120 mg tablets (30-count units) valued at $4,156.56 with a firm fixed price structure. This is a non-set-aside contract, indicating the award was made through open competition. The delivery order is expected to be completed by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Orgovyx is a...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for supply of Orgovyx 120 mg tablets (30-count units) on August 13, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Orgovyx is a gonadotropin-releasing hormone receptor agonist used in the treatment of advanced...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of May 12, 2025. This non-set-aside award was issued on April 21, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical product the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $11,084.16 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 29, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under no set-aside program, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30-unit packages. This firm fixed price delivery order, valued at $2,771.04, is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,771.04 and an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB25D3021Indefinite Delivery Contract
- SPE2DB25D3021-SPE2DB25FQYVADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30) on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical product used in oncology treatment, reflecting the breadth of medical supplies procured through federal contract vehicles to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp has demonstrated capability to fulfill federal medical supply requirements, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/20/25 |